Human Papillomavirus (HPV) Testing Market - Global Outlook and Forecast 2020-2025

Human Papillomavirus (HPV) Testing Market - Global Outlook and Forecast 2020-2025

The global HPV testing market is expected to grow at a CAGR of over 12% during the period 2019–2025.

The following factors are likely to contribute to the growth of the HPV testing market during the forecast period:

  • Increasing Prevalence of HPV Infections
  • Emergence of Point-of-care Diagnostics/Rapid HPV Tests
  • Rise of mRNA Test for Cervical Cancer Screening
  • Increasing Demand for HPV Co-testing
The increased procurement of the latest-generation HPV testing analyzers and test kits, coupled with the high prevalence of HPV-related infections and cancers, especially cervical and vaginal, influences the growth of the global HPV testing market. Traditionally, cervical cancer screening was based on cervical cytology. However, in recent years, several countries and global health bodies have recommended the inclusion of HPV tests for cervical and pre-cancer screening programs, which is likely to boost the market.

The demand for new innovative testing consumables and instruments using advanced techniques such as the HPV mRNA test, which promotes accurate and sensitive diagnostic outcomes, is driving the market growth. Further, with the availability of positive clinical evidence, demonstrating the superiority of the latest generation advanced testing devices, end-users will become increasingly aware of clinical benefits and rapidly adopt these tests as an essential screening tool for cervical cancer screening. Therefore, the improvement in patient management, favorable government initiatives for primary screening, and the rising awareness of advanced testing in developed and developing economies are increasing the adoption globally.

The study considers the present scenario of the HPV testing market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

HPV Testing Market: Segmentation

This research report includes detailed segmentation by products, applications, end-user, and geography. The consumables segment is growing due to the high adoption of advanced testing kits, reagents, and other related consumables to detect and screen cervical cancers globally. The segment is also growing at a fast rate due to the recurring purchase by end-users to perform HPV tests. These screening tests are likely to gain wide acceptance in emerging economies due to favorable government initiatives and the rise in consumer spending power. Therefore, market players are focusing on significant product launches in a low resource setting of emerging countries, thereby accelerating the segment growth. The instruments segment is growing at a slow pace as the procurement of analyzers is capital intensive and the purchasing decision depends on financial resources and budget allocations. However, the increasing availability of automated and compact analyzers/instruments has significantly improved the efficiency and quality of end-user operations. Automation and integration of several diagnostic platforms have led to the introduction of innovative diagnostic analyzers, thereby driving the growth during the forecast period.

The cervical application segment is growing on account of the rise in cervical cancer incidences. The increased focus of market players to launch screening products in low resource countries is expected to drive the cervical application segment during the upcoming years. HPV self-sampling is emerging with the rapid availability of these devices as a potential screening strategy, especially in the US, which is likely to contribute to the growth.

The application of HPV testing for vaginal cancer offers powerful negative predictive values. Therefore, the detection of infection with a high-risk HPV, which produce visible signs, is a powerful tool for vaginal cancer screening. Owing to the benefit of HPV testing, coupled with the rise in the vaginal cancer burden globally, vendors are offering innovative testing devices, which are driving the growth of the vaginal application segment.

The increased focus on enhancing the sensitivity of cervical screening to reduce false-negative diagnoses as well as improve the specificity of molecular tests to detect high-risk human papillomavirus is a major factor contributing to the growth of standard reference laboratories. The availability of standard reference laboratory services for the evaluation of HPV DNA and antibody detection in biological specimens through capacity-building worldwide is another reason for the growth of standard reference laboratories.

Healthcare professionals in hospitals use human papillomavirus testing as a screening procedure for the cervical and other related cancers. The market is likely to grow at a fast pace during the forecast period on account of the adoption of advanced testing products. A majority of patients with high-risk symptoms prefer visiting hospitals for diagnosis due to advanced infrastructure facilities available in major private and public hospitals.

The physicians’ office and clinic segment is expected to grow mainly on account of the growing prevalence of cervical cancers worldwide. These clinics perform laboratory screening through private offices for people with a high risk of cervical and other HPV associated cancers at an affordable cost. Another factor responsible for the rise of this segment is the availability of super-specialty expertise in these clinics.

Market Segmentation by Products
  • Consumables
  • Instruments
Market Segmentation by Applications
  • Cervical Cancers
  • Vaginal Cancers
  • Others
Market Segmentation by End-user
  • Standard Reference Laboratories
  • Hospitals
  • Physicians’ Office and Clinics
Insights by Geography

North America is growing at a significant rate due to the growing preference for HPV tests to detect and screen cervical cancers and other related infections. The presence of a large pool of population with a high risk of developing cervical cancer, the increasing acceptance of HPV testing, and growing awareness of advanced testing procedures have accelerated the market.

Germany, France, the UK, Spain, and Italy are the leading contributors to the Europe market. The presence of highly sophisticated healthcare infrastructure, a high awareness level of advanced HPV screening procedures with high analytic sensitivity for detecting cervical cancers, and increased investment in R&D activities are the major drivers for the growth in the region.

The region has the largest population density and the highest population with a high risk of developing cervical cancers and other associated infections. Japan, China, Australia, South Korea, and India are the major revenue contributors from the region. Japan is the major revenue contributor to the HPV testing market in APAC due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives for an increase in the healthcare access.

Market Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • APAC
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • MEA
  • Turkey
  • South Africa
  • Saudi Arabia
Insights by Vendors

The global HPV testing market is highly competitive and characterized by the presence of several global, regional, and local players. F. Hoffmann-La Roche, QIAGEN, Hologic, and Abbott are the dominant players, and their testing instruments and consumables are widely used by end-users globally. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities. Over the years, these players have been dominating the market as they have introduced safe and efficient products in the market. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market.

Key Vendors
  • Hoffmann-La Roche
  • QIAGEN
  • Hologic
  • Abbott
  • ther Vendors
  • Arbor Vita
  • BD
  • Cepheid
  • DAAN Gene
  • DiaCarta
  • Fujirebio
  • Greiner Bio One International
  • Hybribio
  • IncellDx
  • Norgen Biotek
  • PreTect
  • Seegene
  • Siemens Healthineers
  • Takara Bio
  • Xiamen Zeesan Biotech
  • ZYTOVISION
Key Market Insights

The analysis of the global HPV testing market provides sizing and growth opportunities for the forecast period 2020–2025.
  • Offers sizing and growth prospects of the market for the forecast period 2020–2025.
  • Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
  • Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
  • Delivers a complete overview of segments and the regional outlook of the market.
  • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.


1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by End-users
4.4.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 HPV Infections: An Overview
7.1.1 Background
7.1.2 Types of HPV
7.1.3 Cervical Cancer
7.1.4 HPV Tests
7.1.5 HPV Testing: Market Snapshot
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Prevalence of HPV Infections
8.1.2 Growing Awareness & Favorable Guidelines Endorsing HPV Testing
8.1.3 High Demand for Nucleic Acid Amplification Tests
8.2 Market Growth Restraints
8.2.1 Availability of Alternative Diagnostic Methods for HPV
8.2.2 Increasing Focus on Preventive Measures for HPV Infections
8.2.3 Lower than Expected Market Penetration of HPV Tests
8.3 Market Opportunities and Trends
8.3.1 Emergence of Point-of-care/Rapid HPV Tests
8.3.2 High Growth Potential for HPV Tests in Low Resource Settings of LMICs
8.3.3 Emergence of mRNA Test for Cervical Cancer Screening
8.3.4 Increasing Demand for HPV Co-testing
9 Global HPV Testing Market
9.1 Market Overview
9.2 Market Size & Forecast
9.2.1 By Geography
9.2.2 By Product
9.2.3 By Application
9.2.4 By End-users
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 By Product
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Consumables
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.4 Instruments
10.4.1 Market Overview
10.4.2 Market Size & Forecast
11 By Application
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Cervical Cancer
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Vaginal Cancer
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Others
11.5.1 Market Overview
11.5.2 Market Size & Forecast
12 By End-Users
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Standard Reference Laboratories
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Hospitals
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Physicians’ Offices and Clinics
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 By Geography
13.1 Market Snapshot & Growth Engine
13.2 Overview
14 North America
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Segmentation by Product
14.4 Key Countries
14.4.1 US: Market Size & Forecast
14.4.2 Canada: Market Size & Forecast
15 Europe
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.4 HPV Testing Market Segmentation by Product
15.4.1 UK: Market Size & Forecast
15.4.2 France: Market Size & Forecast
15.4.3 Germany: Market Size & Forecast
15.4.4 Italy: Market Size & Forecast
15.4.5 Spain: Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 HPV Testing Market Segmentation by Product
16.4 Key Countries
16.4.1 Japan: Market Size & Forecast
16.4.2 China: Market Size & Forecast
16.4.3 Australia: Market Size & Forecast
16.4.4 South Korea: Market Size & Forecast
16.4.5 India: Market Size & Forecast
17 Latin America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 HPV Testing Market Segmentation by Product
17.4 Key Countries
17.4.1 Brazil: Market Size & Forecast
17.4.2 Mexico: Market Size & Forecast
17.4.3 Argentina: Market Size & Forecast
18 Middle East & Africa
18.1 Market Overview
18.2 Market Size & Forecast
18.3 HPV Testing Market Segmentation by Product
18.4 Key Countries
18.4.1 Turkey: Market Size & Forecast
18.4.2 South Africa: Market Size & Forecast
18.4.3 Saudi Arabia: Market Size & Forecast
19 Competitive Landscape
19.1 Competition Overview
19.2 Market Share Analysis
19.2.1 F. Hoffmann-La Roche
19.2.2 QIAGEN
19.2.3 Hologic
19.2.4 Abbott
20 Key Vendors
20.1 F. Hoffmann-La Roche
20.1.1 Business Overview
20.1.2 Major Product Offerings
20.1.3 Key Strengths
20.1.4 Key Strategies
20.1.5 Key Opportunities
20.2 QIAGEN
20.2.1 Business Overview
20.2.2 Major Product Offerings
20.2.3 Key Strengths
20.2.4 Key Strategies
20.2.5 Key Opportunities
20.3 Hologic
20.3.1 Business Overview
20.3.2 Major Product Offerings
20.3.3 Key Strengths
20.3.4 Key Strategies
20.3.5 Key Opportunities
20.4 Abbott
20.4.1 Business Overview
20.4.2 Major Product Offerings
20.4.3 Key Strengths
20.4.4 Key Strategies
20.4.5 Key Opportunities
21 Other Prominent Vendors
21.1 Arbor Vita
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.2 BD
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.3 Cepheid
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.4 DAAN Gene
21.4.1 Business Overview
21.4.2 Major Product Offerings
21.5 DiaCarta
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.6 Fujirebio
21.6.1 Business Overview
21.6.2 Major Product Offerings
21.7 Greiner Bio-One International
21.7.1 Business Overview
21.7.2 Major Product Offerings
21.8 Hybribio
21.8.1 Business Overview
21.8.2 Major Product Offerings
21.9 IncellDx
21.9.1 Business Overview
21.9.2 Major Product Offerings
21.10 Norgen Biotek
21.10.1 Business Overview
21.10.2 Major Product Offerings
21.11 PreTect
21.11.1 Business Overview
21.11.2 Major Product Offerings
21.12 Seegene
21.12.1 Business Overview
21.12.2 Major Product Offerings
21.13 Siemens Healthineers
21.13.1 Business Overview
21.13.2 Major Product Offerings
21.14 Takara Bio
21.14.1 Business Overview
21.14.2 Major Product Offerings
21.15 Xiamen Zeesan Biotech
21.15.1 Business Overview
21.15.2 Major Product Offerings
21.16 Zytovision
21.16.1 Business Overview
21.16.2 Major Product Offerings
22 Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 By Product
22.3.2 By Application
22.3.3 By End-users
22.3.4 By Geography
23 Appendix
23.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global HPV Testing Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Symptoms of HPV
Exhibit 4 Different Types of HPV Based on Risk
Exhibit 5 Symptoms of Advanced Cervical Cancer
Exhibit 6 Major Market Dynamics in Global HPV Testing Market
Exhibit 7 Global HPV Testing Market by Geography 2019 (%)
Exhibit 8 Global HPV Testing Market by Product 2019 (%)
Exhibit 9 Impact of Increasing Prevalence of HPV Infections
Exhibit 10 Cervical Cancer Incidence & Mortality Rate
Exhibit 11 Worldwide Prevalence of HPV Types
Exhibit 12 Impact of Growing Awareness & Favorable Guidelines Endorsing HPV Testing
Exhibit 13 Updated Screening Guidelines for Cervical Cancer by US Preventive Services Task Force for Women in the Age Range of 30-65 Years in August 2018
Exhibit 14 Impact of High Demand for Nucleic Acid Amplification Tests
Exhibit 15 Scenarios where HPV DNA Test is Recommended
Exhibit 16 Impact of Availability of Alternative Diagnostic Methods for HPV
Exhibit 17 Key Advantages of Pap Tests
Exhibit 18 Key Advantages of VIA
Exhibit 19 Impact of Increasing Focus on Preventive Measures for HPV Infections
Exhibit 20 Impact of HPV Vaccination on HPV Infections in Various Age Groups
Exhibit 21 Impact of Lower than Expected Market Penetration of HPV Tests
Exhibit 22 Key Factors Hindering the Expected Market Penetration of HPV Testing in Developing Countries
Exhibit 23 Impact of Emergence of Point-of-care/Rapid HPV Tests
Exhibit 24 Impact of High Growth Potential for HPV Tests in Low Resource Settings of LMICs
Exhibit 25 Top 10 Countries with Highest Cervical Cancer Rate in 2018
Exhibit 26 Comparison of Cervical Cancer Mortality Rates in Less Developed and Developed Countries by Age Groups
Exhibit 27 Impact of Emergence of mRNA Test for Cervical Cancer Screening
Exhibit 28 The Most Important Advantages of mRNA HPV Test
Exhibit 29 Impact of Increasing Demand for HPV Co-testing
Exhibit 30 Use of HPV DNA Testing as an Adjunct to Cytology for Cervical Cancer Screening in Women 30 Years and Older
Exhibit 31 Global HPV Testing Market 2019−2025 ($ million)
Exhibit 32 Global HPV Testing Market by Geography
Exhibit 33 Global HPV Testing Market by Product
Exhibit 34 Global HPV Testing Market by Application
Exhibit 35 Global HPV Testing Market by End-users
Exhibit 36 Five Force Analysis 2019
Exhibit 37 Incremental Growth by Product 2019-2025
Exhibit 38 Global HPV Testing Market by Product
Exhibit 39 Global HPV Testing Market Lifecycle by Product
Exhibit 40 Global HPV Testing Market by Product: Incremental Growth
Exhibit 41 Global HPV Testing Market by Product: Absolute Growth
Exhibit 42 Global HPV Testing Market by Product 2019−2025 ($ million)
Exhibit 43 Global HPV Testing Market by Product 2019−2025 (%)
Exhibit 44 Global HPV Testing Market by Consumables: Absolute & Incremental Growth
Exhibit 45 High-risk HPV-induced Cancers
Exhibit 46 HPV Testing Equipment Market 2019−2025 ($ million)
Exhibit 47 Global HPV Testing Market by Instruments: Absolute & Incremental Growth
Exhibit 48 HPV Testing Instruments Market 2019−2025 ($ million)
Exhibit 49 Incremental Growth by Application 2019-2025
Exhibit 50 Global HPV Testing Market by Application
Exhibit 51 Global HPV Testing Market Lifecycle by Application
Exhibit 52 Global HPV Testing Market by Application: Incremental Growth
Exhibit 53 Global HPV Testing Market by Application: Absolute Growth
Exhibit 54 Countries with Highest Cervical Cancer Rate in 2018
Exhibit 55 Potential Uses of HPV Testing
Exhibit 56 HPV Testing Market by Cervical Cancer: Absolute & Incremental Growth
Exhibit 57 Global HPV Testing Market by Cervical Cancer 2019−2025 ($ million)
Exhibit 58 Global Vaginal Cancer Incidence 2018
Exhibit 59 Global HPV Testing Market by Vaginal Cancer: Absolute & Incremental Growth
Exhibit 60 HPV Genotype Distribution in Vaginal Cancer Cases (%)
Exhibit 61 Global HPV Testing Market by Vaginal Cancer 2019−2025 ($ million)
Exhibit 62 Global HPV Testing Market by Other Cancers: Absolute & Incremental Growth
Exhibit 63 Global Oropharyngeal Cancer Incidence 2018
Exhibit 64 Global Vulvar Cancer Incidence 2018
Exhibit 65 Global Anal Cancer Incidence 2018
Exhibit 66 Global Penile Cancer Incidence 2018
Exhibit 67 Global HPV Testing Market by Others 2019−2025 ($ million)
Exhibit 68 Incremental Growth by End-users 2019-2025
Exhibit 69 Global HPV Testing Market by End-users
Exhibit 70 Global HPV Testing Market Lifecycle by End-users
Exhibit 71 Global HPV Testing Market by End-users: Absolute Growth
Exhibit 72 Global HPV Testing Market by End-users: Incremental Growth
Exhibit 73 Global HPV Testing Market by Standard Reference Laboratories: Absolute & Incremental Growth
Exhibit 74 Key Offerings by WHO LabNet for Standard Reference Laboratories
Exhibit 75 Global HPV Testing Market by Standard Reference Laboratories 2019−2025 ($ million)
Exhibit 76 Global HPV Testing Market by Hospitals: Absolute & Incremental Growth
Exhibit 77 Global HPV Testing Market by Hospitals 2019−2025 ($ million)
Exhibit 78 Global HPV Testing Market by Physicians’ Offices and Clinics: Absolute & Incremental Growth
Exhibit 79 Global HPV Testing Market by Physicians’ Offices and Clinics 2019−2025 ($ million)
Exhibit 80 Incremental Growth by Geography 2019-2025
Exhibit 81 Global HPV Testing Market by Geography
Exhibit 82 Global HPV Testing Market Lifecycle by Region
Exhibit 83 Global HPV Testing Market by Geography 2019
Exhibit 84 Global HPV Testing Market by Geography: Absolute Growth
Exhibit 85 Global HPV Testing Market by Geography: Incremental Growth
Exhibit 86 HPV Testing Market in North America
Exhibit 87 North America HPV Testing Market: Absolute & Incremental Growth
Exhibit 88 HPV Testing Market in North America 2019−2025 ($ million)
Exhibit 89 North America: HPV Testing Market by Product 2019 & 2025 (%)
Exhibit 90 North America: HPV Testing Market by Product 2019−2025 ($ million)
Exhibit 91 North America: HPV Testing Market by Product 2019−2025 (%)
Exhibit 92 Incremental Growth in North America 2019−2025
Exhibit 93 HPV Testing Market in US 2019−2025 ($ million)
Exhibit 94 HPV Testing Market in Canada 2019−2025 ($ million)
Exhibit 95 Europe HPV Testing Market 2019
Exhibit 96 Europe HPV Testing Market: Absolute & Incremental Growth
Exhibit 97 HPV Testing Market in Europe 2019–2025 ($ million)
Exhibit 98 Incremental Growth in Europe 2019-2025
Exhibit 99 Europe: HPV Testing Market by Product 2019−2025 ($ million)
Exhibit 100 Europe: HPV Testing Market by Product 2019−2025 (%)
Exhibit 101 HPV Testing Market in UK 2019−2025 ($ million)
Exhibit 102 The YPA Program Mainly Includes
Exhibit 103 HPV Testing Market in France 2019–2025 ($ million)
Exhibit 104 HPV Testing Market in Germany 2019–2025 ($ million)
Exhibit 105 HPV Testing Market in Italy 2019–2025 ($ million)
Exhibit 106 HPV Testing Market in Spain 2019–2025 ($ million)
Exhibit 107 APAC HPV Testing Market 2019
Exhibit 108 APAC HPV Testing Market: Absolute & Incremental Growth
Exhibit 109 HPV Testing Market in APAC 2019–2025 ($ million)
Exhibit 110 APAC: HPV Testing Market by Product 2019−2025 ($ million)
Exhibit 111 APAC: HPV Testing Market by Product 2019−2025 (%)
Exhibit 112 Incremental Growth in APAC 2019-2025
Exhibit 113 HPV Testing Market in Japan 2019–2025 ($ million)
Exhibit 114 HPV Testing Market in China 2019–2025 ($ million)
Exhibit 115 HPV Testing Market in Australia 2019–2025 ($ million)
Exhibit 116 HPV Testing Market in South Korea 2019–2025 ($ million)
Exhibit 117 HPV Testing Market in India 2019–2025 ($ million)
Exhibit 118 Latin America HPV Testing Market 2019
Exhibit 119 Latin America HPV Testing Market: Absolute & Incremental Growth
Exhibit 120 HPV Testing Market in Latin America 2019–2025 ($ million)
Exhibit 121 Latin America: HPV Testing Market by Product 2019−2025 ($ million)
Exhibit 122 Latin America: HPV Testing Market by Product 2019−2025 (%)
Exhibit 123 Incremental Growth in Latin America 2019-2025
Exhibit 124 HPV Testing Market in Brazil 2019–2025 ($ million)
Exhibit 125 HPV Testing Market in Mexico 2019–2025 ($ million)
Exhibit 126 HPV Testing Market in Mexico 2019–2025 ($ million)
Exhibit 127 MEA HPV Testing Market 2019
Exhibit 128 MEA HPV Testing Market: Absolute & Incremental Growth
Exhibit 129 Middle East and North Africa Cervical Cancer Deaths
Exhibit 130 HPV Testing Market in MEA 2019–2025 ($ million)
Exhibit 131 MEA: HPV Testing Market by Product 2019−2025 ($ million)
Exhibit 132 MEA: HPV Testing Market by Product 2019−2025 (%)
Exhibit 133 Incremental Growth in MEA 2019-2025
Exhibit 134 HPV Testing Market in Turkey 2019–2025 ($ million)
Exhibit 135 HPV Testing Market in South Africa 2019–2025 ($ million)
Exhibit 136 HPV Testing Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 137 Global HPV Testing Market Share: Vendors Share 2019
Exhibit 138 F. Hoffmann-La Roche: Revenue by Business Segments in 2017−2018 ($ billion)
Exhibit 139 F. Hoffmann-La Roche: R&D Expenditure in 2016−2018 ($ billion)
Exhibit 140 F. Hoffmann-La Roche: Revenue by Geography ($ billion)
Exhibit 141 QIAGEN: Revenue by Business Segments in 2017−2018 ($ million)
Exhibit 142 QIAGEN: R&D Expenditure in 2016−2018 ($ million)
Exhibit 143 QIAGEN: Revenue by Geography in 2018 ($ million)
Exhibit 144 Hologic: Revenue by Segments 2018−2019 ($ million)
Exhibit 145 Hologic: R&D Expenditure 2017−2019 ($ million)
Exhibit 146 Hologic: Revenue by Geography 2019 ($ million)
Exhibit 147 Abbott: Revenue by Segments 2017−2018 ($ million)
Exhibit 148 Abbott: R&D Expenditure 2016−2018 ($ million)
Exhibit 149 Abbott: Revenue by Geography ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2014−2019
Table 3 High-risk HPV-induced Cancers
Table 4 Major Vendors Offering HPV Testing Solutions
Table 5 Market Penetration of HPV Test by Regions
Table 6 Commercially Available POC HPV Products
Table 7 Absolute Growth of HPV Testing in Developed and Emerging Economies (%)
Table 8 Commercially Available mRNA Test
Table 9 List of Key HPV Testing Instruments from Market Players
Table 10 Key HPV Diagnostic Analyzers Available in the Market
Table 11 Significant Players Offering HPV Testing Products for the Detection of Cervical Cancer
Table 12 Classification of HPV Associated Penile Carcinomas, Relative Frequency and Mean Cancer-Specific Mortality by WHO
Table 13 Healthcare Expenditure as Percent of GDP in Major Latin American Countries
Table 14 Global HPV Testing Market: Top Vendors Ranking
Table 15 F. Hoffmann-La Roche: Key Product Offerings
Table 16 QIAGEN: Key Product Offerings
Table 17 Hologic: Key Product Offerings
Table 18 Abbott: Key Product Offerings
Table 19 Arbor Vita: Key Product Offerings
Table 20 BD: Key Product Offerings
Table 21 Cepheid: Key Product Offerings
Table 22 DAAN Gene: Key Product Offerings
Table 23 DiaCarta: Key Product Offerings
Table 24 Fujirebio: Key Product Offerings
Table 25 Greiner Bio-One International: Key Product Offerings
Table 26 Hybribio: Key Product Offerings
Table 27 IncellDx: Key Product Offerings
Table 28 Norgen Biotek: Key Product Offerings
Table 29 PreTect: Key Product Offerings
Table 30 Seegene: Key Product Offerings
Table 31 Siemens Healthineers: Key Product Offerings
Table 32 Takara Bio: Key Product Offerings
Table 33 Xiamen Zeesan Biotech: Key Product Offerings
Table 34 ZYTOVISION: Key Product Offerings
Table 35 Global HPV Testing Market by Product ($ million)
Table 36 Global HPV Testing Market by Product (%)
Table 37 Global HPV Testing Market by Application ($ million)
Table 38 Global HPV Testing Market by Application (%)
Table 39 Global HPV Testing Market by End-users ($ million)
Table 40 Global HPV Testing Market by End-users (%)
Table 41 Global HPV Testing Market by Geography ($ million)
Table 42 Global HPV Testing Market by Geography (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook